FEBS Letters
cAMP‐induced decrease in cell‐surface laminin receptor and cellular prion protein attenuates amyloid‐β uptake and amyloid‐β‐induced neuronal cell death
FEBS Letters, Volume 596, Issue 22, Page 2914-2927, November 2022.
FEBS Letters
Loss of function of an Arabidopsis homologue of JMJD6 suppresses the dwarf phenotype of acl5, a mutant defective in thermospermine biosynthesis
FEBS Letters, Volume 596, Issue 23, Page 3005-3014, December 2022.
FEBS Letters
Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptors
FEBS Letters, Volume 596, Issue 24, Page 3107-3123, December 2022.
FEBS Letters
The immunoreceptor SLAMF8 promotes the differentiation of follicular dendritic cell‐dependent monocytic cells with B cell‐activating ability
FEBS Letters, Volume 596, Issue 20, Page 2659-2667, October 2022.
FEBS Letters
His‐163 is a stereospecific proton donor in the mechanism of d‐glucosaminate‐6‐phosphate ammonia‐lyase
FEBS Letters, Volume 596, Issue 18, Page 2441-2448, September 2022.
FEBS Letters
Structural characterisation of a MAPR‐related archaeal cytochrome b5M protein
FEBS Letters, Volume 596, Issue 18, Page 2409-2417, September 2022.
FEBS Letters
The sphingolipid anteome: implications for evolution of the sphingolipid metabolic pathway
FEBS Letters, Volume 596, Issue 18, Page 2345-2363, September 2022.
FEBS Letters
The first crystal structure of a xylobiose‐bound xylobiohydrolase with high functional specificity from the bacterial glycoside hydrolase family 30, subfamily 10
FEBS Letters, Volume 596, Issue 18, Page 2449-2464, September 2022.
FEBS Letters
Expanding the antiviral potential of the mosquito lipid‐transfer protein AEG12 against SARS‐CoV‐2 using hydrophobic antiviral ligands
FEBS Letters, Volume 596, Issue 19, Page 2555-2565, October 2022.